Skip to main content

Table 3 Patient and treatment characteristics and their relationship to ΔSCORE

From: Which patient and treatment factors are related to successful cardiovascular risk score reduction in general practice? Results from a randomized controlled trial

 

n (%) unless otherwise indicated

n missing

Univariate analysis

Multivariate analysis

   

B

95% CI

R2(adj. R2)

B

95% CI

Patient characteristics:

       

Sex (male/female) n (%) male

123 (69)

0

0.246

−0.638, 1.131

0.002 (−0.004)

0.666

−0.349, 1.681

Age (years) Mean (SD)

65 (5)

0

0.012

−0.063, 0.087

0.001 (−0.005)

0.038

−0.041, 0.118

Level of education (4 levels) n (%):

 

2

  

0.015 (−0.003)

  

1: No education or only primary education**

17 (10)

      

2: Lower secondary education

74 (42)

 

1.012

−0.458, 2.482

 

0.322

−1.003, 1.648

3: Higher secondary education

47 (26)

 

1.183

−0.363, 2.730

 

0.621

−0.812, 2.055

4: College or university

38 (21)

 

1.157

−0.438, 2.751

 

−0.213

−1.695, 1.270

SCORE at baseline (%) Mean (SD)

8.6 (4.1)

0

−0.226

−0.321, −0.130*

0.111 (0.105)

−0.246

−0.363, −0.128*

Treatment characteristics:

       

Treatment group (control/intervention) n (%) interv.

89 (50)

0

−0.387

−1.203, 0.429

0.005 (−0.001)

0.722

−0.223, 1.667

Consultation time (minutes) Mean (SD)

97 (64)

3

−0.012

−0.018, −0.005*

0.074 (0.069)

0.000

−0.009, 0.009

Treatment intensity (%) Mean (SD)

79 (24)

1

−0.024

−0.040, −0.007*

0.043 (0.037)

−0.009

−0.026, 0.008

Home blood pressure device

43 (24)

0

−1.557

−2.484, −0.630*

0.059 (0.053)

−0.489

−1.474, 0.496

Home weighing scale

42 (24)

0

−1.238

−2.183, −0.292*

0.037 (0.031)

−1.138

−2.356, 0.080

Home pedometer

30 (17)

0

−0.940

−2.024, 0.144

0.016 (0.011)

0.115

−1.345, 1.576

More than one visit for smoking

27 (15)

0

−1.231

−2.356, −0.105*

0.026 (0.020)

−0.644

−1.712, 0.424

New/changed medication for cholesterol

22 (12)

0

−3.426

−4.559, −2.292*

0.168 (0.163)

−2.067

−3.247, −0.886*

New/changed medication for hypertension

46 (26)

0

−2.195

−3.071, −1.320*

0.122 (0.117)

−1.051

−2.039, −0.062*

  1. 95% CI= 95% confidence interval of B, R2 = explained variance, adj.=adjusted. *= significant; **=reference category, Multivariate analysis R2= 0.360 (adjusted R2= 0.298).